SSTI
Shotspotter Inc
5.50$
-1.6%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.7% | +124.6% | +30.2% | +28.5% | +9.5% | +9.0% | +69.8% | +14.8% | -2.9% | -0.8% | |
| – | -5.4% | +254.5% | +11.1% | +48.5% | -22.5% | +10.1% | +30.3% | -12.7% | +11.6% | +11.6% | |
| – | -6.3% | +406.3% | -47.8% | +140.3% | -34.7% | -2.5% | -33.0% | -45.6% | +131.2% | +19.8% | |
| – | -6.3% | +406.3% | -47.8% | +140.3% | -34.7% | -2.5% | -33.0% | -45.6% | +131.2% | +19.8% | |
| – | -9.6% | +63.0% | +288.7% | -9.1% | -6.9% | +24.9% | +91.9% | -0.8% | -17.1% | +12.2% | |
| – | +21.0% | +53.3% | +93.8% | +7.9% | +25.8% | +15.6% | – | – | – | – | |
| – | +27.7% | +29.4% | +42.3% | +3.7% | -5.2% | +21.6% | +11.4% | – | – | – | |
| – | – | – | – | +0.0% | +103.8% | +0.2% | +715.7% | +48.9% | +0.0% | +0.0% | |
| – | +26.9% | +43.9% | +154.7% | +2.9% | +5,739.4% | -6.7% | +101.4% | +35.2% | -10.2% | -11.6% | |
| – | +12.8% | -67.2% | +24.7% | +11.2% | -3.9% | +20.2% | +60.6% | +7.1% | -2.7% | -1.3% | |
| – | +57.3% | +39.4% | +35.9% | +12.4% | -4.5% | +11.4% | +55.1% | +11.8% | -6.3% | +2.4% | |
| – | -38.9% | +400.6% | +24.3% | -92.7% | +60.3% | -15.5% | +112.2% | +817.5% | -38.4% | +2.3% | |
| – | +44.3% | +21.8% | -19.7% | -9.8% | +1.1% | +33.1% | +2.9% | +85.6% | +13.6% | +10.1% | |
| – | +15.1% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | +41.0% | +58.9% | +25.9% | -1.4% | +80.2% | +22.7% | -3.2% | -0.3% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -2.7% | +70.5% | +12.1% | -1.0% | -0.7% | +5.8% | +0.9% | +2.3% | +0.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.